ask="1.96"
ask_size="500"
average_daily_volume="2089560"
bid="1.75"
bid_size="100"
book_value="1.37"
change="-0.12"
change_from_200_day_moving_average="-3.26"
change_from_50_day_moving_average="0.28"
change_from_52_week_high="-6.38"
change_From_52_week_low="0.64"
change_in_percent="-6.12%"
close="1.84"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.34"
ebitda="-82.29M"
eps_estimate_current_year="-0.39"
eps_estimate_next_quarter="-0.14"
eps_estimate_next_year="-0.73"
ex_dividend_date="N/A"
float_shares="62709000"
high="1.98"
high_52_weeks="8.22"
last_trade_date="1/19/2017"
last_trade_price="1.84"
last_trade_size="14080"
last_trade_time="4:00pm"
low="1.83"
low_52_weeks="1.20"
market_capitalization="136.48M"
moving_average_200_day="5.10"
moving_average_50_day="1.56"
name="Arrowhead Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="1.80"
open="1.98"
pe_ratio="N/A"
peg_ratio="-0.76"
percent_change_from_200_day_moving_average="-63.93%"
percent_change_from_50_day_moving_average="+17.61%"
percent_change_from_52_week_high="-77.62%"
percent_change_from_52_week_low="+53.33%"
previous_close="1.96"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.43"
price_per_sales="918.19"
revenue="158333.00"
shares_outstanding="74173000"
short_ratio="3.03"
stock_exchange="NMS"
symbol="ARWR"
volume="765057"
weeks_range_52="1.20 - 8.22"
